NO133716C - - Google Patents
Info
- Publication number
- NO133716C NO133716C NO2396/70A NO239670A NO133716C NO 133716 C NO133716 C NO 133716C NO 2396/70 A NO2396/70 A NO 2396/70A NO 239670 A NO239670 A NO 239670A NO 133716 C NO133716 C NO 133716C
- Authority
- NO
- Norway
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB3137169 | 1969-06-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO133716B NO133716B (US20110009641A1-20110113-C00116.png) | 1976-03-08 |
NO133716C true NO133716C (US20110009641A1-20110113-C00116.png) | 1976-06-16 |
Family
ID=10322106
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO2396/70A NO133716C (US20110009641A1-20110113-C00116.png) | 1969-06-20 | 1970-06-19 |
Country Status (19)
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1376892A (en) * | 1970-11-12 | 1974-12-11 | Glaxo Lab Ltd | 2beta-substituted-3alpha-hydroxysteroids and their esters |
GB1377609A (en) * | 1970-12-17 | 1974-12-18 | Glaxo Lab Ltd | 3alpha-hydroxy-5alpha-pregnane compounds |
GB1377608A (en) * | 1970-12-17 | 1974-12-18 | Glaxo Lab Ltd | 3alpha-hydroxy or acyloxy pregnene-21-ethers |
US3917830A (en) * | 1970-12-17 | 1975-11-04 | Glaxo Lab Ltd | Steroidal anaesthetic composition for intraveneous injection |
US3900561A (en) * | 1970-12-17 | 1975-08-19 | Glaxo Lab Ltd | Pharmaceutical compositions |
GB1430932A (en) * | 1972-05-05 | 1976-04-07 | Glaxo Lab Ltd | 21-fluoro-pregnanes |
GB1436324A (en) * | 1972-05-12 | 1976-05-19 | Glaxo Lab Ltd | Anaesthetic 3alpha-hydroxy pregnanes |
IT1202370B (it) * | 1976-07-12 | 1989-02-09 | Hoffmann La Roche | Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti |
IT1204778B (it) | 1986-02-04 | 1989-03-10 | Mazzarella Basilio | Formulazioni farmaceutiche iniettabili di principi attivi ad attivita' anestetica generale |
IE920759A1 (en) * | 1991-03-29 | 1992-10-07 | Generali Costruzioni Srl | Standardized step module for building prefabricated¹staircases, process for producing such module, prefabricated¹staircase and process for assembling prefabricated¹staircases |
CZ300694A3 (en) * | 1993-12-02 | 1996-05-15 | Akzo Nobel Nv | Substituted 2beta-morpholinandrostane derivatives, process of their preparation, their use for preparing pharmaceutical preparations and pharmaceutical compositions containing thereof |
US6787530B1 (en) | 1996-08-23 | 2004-09-07 | Monash University | Use of pregnane-diones as analgesic agents |
EP1728505B1 (en) * | 2004-03-24 | 2014-06-04 | Takeda Pharmaceutical Company Limited | Preparation with elevated content |
AU2019297195A1 (en) | 2018-07-03 | 2021-01-14 | Drawbridge Pharmaceuticals Pty Ltd | Neuroactive steroids and methods of preparation |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1281205A (fr) * | 1956-12-21 | 1962-01-12 | Organon Nv | Procédé d'obtention de composés de la série du prégnane |
-
1969
- 1969-06-20 GB GB3137169A patent/GB1317184A/en not_active Expired
- 1969-12-15 BR BR215173/69A patent/BR6915173D0/pt unknown
-
1970
- 1970-06-08 ZA ZA703861A patent/ZA703861B/xx unknown
- 1970-06-12 IL IL34713A patent/IL34713A/xx unknown
- 1970-06-15 PH PH11533A patent/PH11156A/en unknown
- 1970-06-17 US US00047163A patent/US3714352A/en not_active Expired - Lifetime
- 1970-06-18 BE BE752165D patent/BE752165A/xx not_active IP Right Cessation
- 1970-06-18 SE SE7008517A patent/SE406038B/xx unknown
- 1970-06-19 FR FR707022783A patent/FR2052999B1/fr not_active Expired
- 1970-06-19 NO NO2396/70A patent/NO133716C/no unknown
- 1970-06-19 DE DE2065513*A patent/DE2065513A1/de not_active Withdrawn
- 1970-06-19 AT AT555570A patent/AT315375B/de active
- 1970-06-19 NL NLAANVRAGE7009002,A patent/NL169480C/xx not_active IP Right Cessation
- 1970-06-19 CA CA085,973A patent/CA1001073A/en not_active Expired
- 1970-06-19 ES ES380943A patent/ES380943A1/es not_active Expired
- 1970-06-19 DE DE2065332*A patent/DE2065332A1/de active Pending
- 1970-06-19 FR FR7022782A patent/FR2052998B1/fr not_active Expired
- 1970-06-19 IE IE800/70A patent/IE35203B1/xx unknown
- 1970-06-19 DK DK317970AA patent/DK129390B/da unknown
- 1970-06-19 AT AT710872A patent/AT326826B/de not_active IP Right Cessation
- 1970-06-19 DE DE2030402A patent/DE2030402B2/de active Granted
- 1970-06-22 CH CH941770A patent/CH578016A5/xx not_active IP Right Cessation
-
1972
- 1972-09-16 JP JP7293152A patent/JPS5140135B1/ja active Pending
-
1973
- 1973-01-05 US US00321274A patent/US3781435A/en not_active Expired - Lifetime
-
1974
- 1974-02-19 SE SE7402197A patent/SE401512B/xx unknown